@article{article, title  = {{Multiple‐Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid‐Beta Precursor Protein for Alzheimer’s Disease}},

 publisher = {{Wiley}},

 url = {{https://doi.org/10.1002/alz70859_097989 }},

 year = {{2025}},

 month = {{12}},

 author = {{Cohen S and Ducharme S and Brosch JR and Vijverberg EGB and Blackburn DJ and McDade E and Sostelly A and Chaudhari S and Farrugia L and Deering RW and Shirvan J et al}},

 doi = {{10.1002/alz70859_097989}},

 volume = {{21}},

 journal = {{Alzheimer's & Dementia}},

 issue = {{S5}},

 note = {{Accessed on 2026/01/11}}}